99% Purity CAS 36703-88-5 Inosine Pranobex Material Inosine Pranobex Powder Inosine Pranobex

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Inosine Pranobex
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Inosine Pranobex
• Name: Inosine Pranobex Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 36703-88-5
• Mf: C52h78n10o17
• MW: 1115.23252
• Melting Point: 140-145°c
• Boiling Point: 732.8 °c at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

99% Purity CAS 36703-88-5 Inosine Pranobex Material Inosine Pranobex Powder Inosine Pranobex

Product Description

Product Details

Product name	Inosine Pranobex
Cas number	36703-88-5
Apperance	White powder
MF	C52H78N10O17
MW	1115.23252

Isopinosine is an organic substance with a chemical formula of C52H78N10O17, slightly yellow or colorless powder, slightly bitter, easy to absorb moisture, soluble in water, is inosine and is combined with dimethylaminoisopropanol and p-acetaminobenzoate Complex.

Isoprinosine is an immunomodulatory drug. In vitro experiments have shown that it can enhance the immune response of PHA or antigen, promote the differentiation and proliferation of T lymphocytes, and can stimulate the differentiation of B lymphocytes by activating TH cells or macrophages And produce antibodies.

Application&Function

Isoprinosine is used for a variety of viral infections, including subacute sclerosing panencephalitis, acute viral meningitis, herpes zoster, skin herpes, influenza and thrush, herpes virus keratitis, uveitis, acquired Sexual immunodeficiency syndrome (AIDS), immunodeficiency disease, etc.

Isoprinosine is used as a therapeutic agent for malignant lymphoma, myeloma, early malignant melanoma, and combined with surgery to treat patients with esophageal cancer, gastric cancer, rectal cancer, and thyroid cancer.

Specification